Given the potential roles for cross talk effects between cGMP and the cAMP-PKA (protein kinase A) axis, whether the antiarrhythmic effects of PDE5 inhibition extend to catecholamine-induced arrhythmia is an important consideration in future studies. This evidence concerns the gene PDE5A and cardiac arrhythmia.